Buchumschlag

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: La Rosée, Paul (BerichterstatterIn) , Müller, Martin Christian (BerichterstatterIn) , Erben, Philipp (BerichterstatterIn) , Saußele, Susanne (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: Annals of hematology
Year: 2013, Jahrgang: 92, Heft: 10, Pages: 1345-1350
ISSN:0939-5555
Online-Zugang: Volltext
Verfasserangaben:La Rosee, Paul ... Mueller, Martin C.; Erben, Philipp ... Saussele, Susanne ...

MARC

LEADER 00000caa a22000002c 4500
001 163325691X
003 DE-627
005 20220815223324.0
007 tu
008 131001s2013 xx ||||| 00| ||eng c
035 |a (DE-627)163325691X 
035 |a (DE-576)393979709 
035 |a (DE-599)BSZ393979709 
035 |a (OCoLC)1341155224 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib  |c La Rosee, Paul ... Mueller, Martin C.; Erben, Philipp ... Saussele, Susanne ... 
264 1 |c 2013 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
700 1 |a La Rosée, Paul  |d 1969-  |0 (DE-588)122116674  |0 (DE-627)081745966  |0 (DE-576)293100357  |4 oth 
700 1 |a Müller, Martin Christian  |d 1972-  |0 (DE-588)121360296  |0 (DE-627)705409236  |0 (DE-576)181482819  |4 oth 
700 1 |a Erben, Philipp  |d 1973-  |0 (DE-588)128501014  |0 (DE-627)373920997  |0 (DE-576)297181661  |4 oth 
700 1 |a Saußele, Susanne  |d 1968-  |0 (DE-588)115839860  |0 (DE-627)69162786X  |0 (DE-576)29010694X  |4 oth 
773 0 8 |i In  |t Annals of hematology  |d Berlin : Springer, 1991  |g 92(2013), 10, Seite 1345-1350  |w (DE-627)130956759  |w (DE-600)1064950-5  |w (DE-576)025101188  |x 0939-5555  |7 nnas  |a Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib 
773 1 8 |g volume:92  |g year:2013  |g number:10  |g pages:1345-1350  |g extent:6  |a Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib 
951 |a AR 
992 |a 20131001 
993 |a Article 
994 |a 2013 
998 |g 115839860  |a Saußele, Susanne  |m 115839860:Saußele, Susanne  |d 60000  |d 61200  |e 60000PS115839860  |e 61200PS115839860  |k 0/60000/  |k 1/60000/61200/  |p 8 
998 |g 128501014  |a Erben, Philipp  |m 128501014:Erben, Philipp  |d 60000  |d 61200  |e 60000PE128501014  |e 61200PE128501014  |k 0/60000/  |k 1/60000/61200/  |p 6 
998 |g 121360296  |a Müller, Martin Christian  |m 121360296:Müller, Martin Christian  |d 60000  |d 61200  |e 60000PM121360296  |e 61200PM121360296  |k 0/60000/  |k 1/60000/61200/  |p 5 
999 |a KXP-PPN163325691X  |e 3286586277 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"part":{"extent":"6","issue":"10","pages":"1345-1350","year":"2013","volume":"92","text":"92(2013), 10, Seite 1345-1350"},"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"1991","publisher":"Springer","dateIssuedDisp":"1991-2024"}],"language":["eng"],"pubHistory":["62.1991-Volume 103, number 12 (2024)"],"corporate":[{"role":"isb","display":"Deutsche Gesellschaft für Hämatologie und Onkologie"},{"role":"isb","display":"Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie"},{"role":"isb","display":"Gesellschaft für Thrombose- und Hämostaseforschung"},{"role":"isb","display":"Österreichische Gesellschaft für Hämatologie und Onkologie"}],"recId":"130956759","id":{"eki":["130956759"],"zdb":["1064950-5"],"issn":["0939-5555"]},"note":["Fortgesetzt als Online-Ausgabe","Beteil. Körp. anfangs: Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie"],"title":[{"title_sort":"Annals of hematology","subtitle":"organ of Deutsche Gesellschaft für Hämatologie und Onkologie, Gesellschaft für Thrombose- und Hämostaseforschung, Österreichische Gesellschaft für Hämatologie und Onkologie","title":"Annals of hematology"}],"disp":"Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinibAnnals of hematology","type":{"bibl":"periodical"}}],"language":["eng"],"person":[{"role":"oth","family":"La Rosée","given":"Paul","display":"La Rosée, Paul"},{"display":"Müller, Martin Christian","given":"Martin Christian","family":"Müller","role":"oth"},{"given":"Philipp","family":"Erben","role":"oth","display":"Erben, Philipp"},{"family":"Saußele","role":"oth","given":"Susanne","display":"Saußele, Susanne"}],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"recId":"163325691X","id":{"eki":["163325691X"]},"physDesc":[{"extent":"6 S."}],"title":[{"title_sort":"Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib","title":"Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib"}],"type":{"bibl":"article-journal"},"name":{"displayForm":["La Rosee, Paul ... Mueller, Martin C.; Erben, Philipp ... Saussele, Susanne ..."]}} 
SRT |a IMPROVEDTO2013 

Ähnliche Einträge